ÂÜÀòÂÒÂ×

Eric Delpy is a seasoned professional in the field of pharmacology, currently serving as the Scientific Director at Biotrial since February 2022. Prior experience includes roles as Non-Clinical Development Manager and Design & Development Manager at HEMARINA from January 2018 to February 2022, and Director of Non-Clinical Operations at Biotrial Pharmacology from 1998 to March 2017. Delpy has a strong background in preclinical pharmacology, ensuring compliance with Good Laboratory Practices, and leading cardiovascular and respiratory project studies. Earlier research positions include time at Paris-Sud University and INSERM, contributing to notable publications on cardiotoxicity and pharmacological effects. Delpy holds a PhD in Pharmacology and multiple degrees in related fields from prestigious French universities.